
Prescription Drug Name:
ATENOLOL TABLETS USP, 0787, 0752, 0753, Rx only
ID:
3b76067a-858a-0abb-e054-00144ff8d46c
Code:
34391-3
DESCRIPTION
id: 3b7658ac-598b-4f22-e054-00144ff88e88
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
1-selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2′-hydroxy-3′-[(1-methylethyl) amino] propoxy]-. The molecular and structural formulas are:
14H
22N
2O
3 M.W. (free base) 266.34
CLINICAL PHARMACOLOGY
id: 3b7658ac-598c-4f22-e054-00144ff88e88
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
1-selective (cardioselective) beta-adrenergic receptor blocking agent without membrane stabilizing or intrinsic sympathomimetic (partial agonist) activities. This preferential effect is not absolute, however, and at higher doses, atenolol inhibits beta
2-adrenoreceptors, chiefly located in the bronchial and vascular musculature.
CONTRAINDICATIONS
id: 3b7658ac-5994-4f22-e054-00144ff88e88
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
ADVERSE REACTIONS
id: 3b7658ac-59ae-4f22-e054-00144ff88e88
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
|
(Foreign + U.S. Studies) |
|||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
POTENTIAL ADVERSE EFFECTS
id: 3b7658ac-59b0-4f22-e054-00144ff88e88
displayName: SPL UNCLASSIFIED SECTION
FDA Article Code: 42229-5
OVERDOSAGE
id: 3b7658ac-59b7-4f22-e054-00144ff88e88
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5
2 stimulant such as isoproterenol or terbutaline and/or aminophylline.
HOW SUPPLIED
id: 3b76067a-858b-0abb-e054-00144ff8d46c
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
Package/Label Display Panel-Bottle of 100
id: 3b76a18c-0644-3f54-e054-00144ff8d46c
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4